About 1-[(2-chlorophenyl)methyl]-2-(4,5-dihydro-1H-imidazol-2-yl)-4-ethylpiperazine
1-[(2-chlorophenyl)methyl]-2-(4,5-dihydro-1H-imidazol-2-yl)-4-ethylpiperazine (PubChem CID 10542738) has the molecular formula C16H23ClN4
and a molecular weight of 306.84 g/mol. Its IUPAC name is 1-[(2-chlorophenyl)methyl]-2-(4,5-dihydro-1H-imidazol-2-yl)-4-ethylpiperazine.
Analyze 1-[(2-chlorophenyl)methyl]-2-(4,5-dihydro-1H-imidazol-2-yl)-4-ethylpiperazine with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of 1-[(2-chlorophenyl)methyl]-2-(4,5-dihydro-1H-imidazol-2-yl)-4-ethylpiperazine?
The IUPAC name of 1-[(2-chlorophenyl)methyl]-2-(4,5-dihydro-1H-imidazol-2-yl)-4-ethylpiperazine (CID 10542738) is 1-[(2-chlorophenyl)methyl]-2-(4,5-dihydro-1H-imidazol-2-yl)-4-ethylpiperazine.
What is the SMILES notation for 1-[(2-chlorophenyl)methyl]-2-(4,5-dihydro-1H-imidazol-2-yl)-4-ethylpiperazine?
The canonical SMILES for 1-[(2-chlorophenyl)methyl]-2-(4,5-dihydro-1H-imidazol-2-yl)-4-ethylpiperazine is CCN1CCN(Cc2ccccc2Cl)C(C2=NCCN2)C1.
What is the InChIKey of 1-[(2-chlorophenyl)methyl]-2-(4,5-dihydro-1H-imidazol-2-yl)-4-ethylpiperazine?
The InChIKey is NDWNJXRWXGPFIM-UHFFFAOYSA-N. The full InChI is InChI=1S/C16H23ClN4/c1-2-20-9-10-21(11-13-5-3-4-6-14(13)17)15(12-20)16-18-7-8-19-16/h3-6,15H,2,7-12H2,1H3,(H,18,19).
What are the key properties of 1-[(2-chlorophenyl)methyl]-2-(4,5-dihydro-1H-imidazol-2-yl)-4-ethylpiperazine?
1-[(2-chlorophenyl)methyl]-2-(4,5-dihydro-1H-imidazol-2-yl)-4-ethylpiperazine has a molecular weight of 306.84 g/mol, XLogP of 1.85, 4 rotatable bonds, 1 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for 1-[(2-chlorophenyl)methyl]-2-(4,5-dihydro-1H-imidazol-2-yl)-4-ethylpiperazine is sourced from PubChem (CID 10542738), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).